Nippon Paint Holdings Earnings Call Transcripts
Fiscal Year 2025
-
Record-high revenue and profit were achieved, with strong margin improvements and EPS growth exceeding guidance. FY 2026 outlook is positive but more conservative, reflecting ongoing economic challenges in China and Europe, while disciplined capital allocation and M&A remain strategic priorities.
-
Management reaffirmed a disciplined M&A and asset assembler strategy, targeting both organic and inorganic growth. China and Turkey remain key markets, with China focusing on margin and risk management and Turkey achieving strong market share gains. Adjusted EPS guidance for 2025 is JPY 74.1, with a 15.3% CAGR since 2018.
-
Q3 saw record revenue and profit, with strong growth in both organic and inorganic segments despite currency headwinds. Guidance for FY 2025 remains unchanged, with margin improvements and robust performance in China, AOC, and other key regions. Share buyback and stable dividend policy reaffirmed.
-
Record-high revenue and profit achieved despite FX headwinds and tough global markets, with strong cost control and margin improvement. Outlook remains cautious, focusing on profit over revenue growth, and guidance reflects continued cost discipline and M&A-driven strategy.
-
Q1 FY2025 delivered record revenue and operating profit, driven by strong Japan and China performance, margin improvements, and new consolidations. Guidance remains unchanged, with management cautious on FX and macro risks but optimistic on resilience and profitability.
-
The strategy update reaffirmed a focus on compounding EPS through disciplined M&A and organic growth, with the AOC acquisition driving a significant upward revision in FY2025 guidance. Strong cash flow, prudent cost control, and a decentralized management approach underpin resilience across regions, while shareholder value remains the core mission.
Fiscal Year 2024
-
Record revenue and profit were achieved in 2024, with strong growth across most regions and improved margins. 2025 guidance forecasts further revenue and profit increases, with the AOC acquisition expected to significantly boost EPS once completed.
-
Record Q3 revenue achieved despite flat operating profit and regional challenges. Q4 is expected to see revenue and profit exceed initial forecasts, with stable raw material costs and new acquisitions set to contribute. China and Europe remain difficult, but Pacific and Indonesia show resilience.
-
A major acquisition of a US-based specialty formulator will boost annual EPS by 30% and strengthen the group’s position in specialty chemicals. The $4.35 billion deal, funded by debt, is expected to close in H1 FY2025 and will be managed by the existing leadership team.
-
Q2 FY2024 saw strong revenue and profit growth, with NIPSEA China and the Americas performing well despite FX volatility and regional challenges. Full-year guidance is maintained, with stable raw material costs and cautious optimism for H2.